作者：
Sheppard,K.E. [1]
;
Cullinane,C. [2]
;
Hannan,K.M. [3]
;
Wall,M. [4]
;
Chan,J. [5]
;
Barber,F. [6]
;
Foo,J. ;
Cameron,D. ;
Neilsen,A. ;
Ng,P. ;
Ellul,J. ;
Kleinschmidt,M. ;
Kinross,K.M. ;
Bowtell,D.D. ;
Christensen,J.G. ;
Hicks,R.J. ;
Johnstone,R.W. ;
McArthur,G.A. ;
Hannan,R.D. ;
Phillips,W.A. ;
Pearson,R.B.
作者单位：
Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Locked Bag 1, Melbourne, VIC 8006
[1]
Surgical Oncology, Peter MacCallum Cancer Centre, Locked Bag 1, Melbourne, VIC 8006, Australia, Sir
[2]
Pfizer Corporation, San Diego, CA, United States
[3]
Translational Research Laboratory, Peter MacCallum Cancer Centre, Locked Bag 1, Melbourne, VIC 8006
[4]
Oncogenic Signalling and Growth Control, Peter MacCallum Cancer Centre, Locked Bag 1, Melbourne
[5]
Cancer Genomics, Peter MacCallum Cancer Centre, Locked Bag 1, Melbourne, VIC 8006, Australia, Sir
[6]
发布时间
2018-09-20
换一批
![European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)](https://cdnimg.med.wanfangdata.com.cn/imgs/qkindeximg/N2007EPST0000700/N2007EPST0000700.jpg)
